CAS No. |
914454-03-8 |
|---|---|
中文名称 |
2-((1R,4S,7S,13S,16R,21R,24S,27S,30S,33S,36S,39S,42R,45S,48S,54S,60S,63R,68R,71S,77S)-63-氨基-13,45,54,60-四(4-氨基丁基)-16-氨甲酰基-4,36-双(3-胍基丙基)-27-(4-羟基苄基)-71-((R)-1-羟基乙基)-7,39,77-三(羟甲基)-33-异丁基-48-甲基-30-(2-(甲硫基)乙基)-2,5,8,11,14,23,26,29,32,35,38,41,44,47,50,53,56,59,62,69,72,75,78,85-二十四氧代-18,19,65,66,81,82-六硫杂-3,6,9,12,15,22,25,28,31,34,37,40,43,46,49,52,55,58,61,70,73,76,79,84-二十四氮杂三环[40.37.4.2^21,68]五十八烷-24-基)乙酸--乙酸(1/1) |
英文名称 |
2-((1R,4S,7S,13S,16R,21R,24S,27S,30S,33S,36S,39S,42R,45S,48S,54S,60S,63R,68R,71S,77S)-63-amino-13,45,54,60-tetrakis(4-aminobutyl)-16-carbamoyl-4,36-bis(3-guanidinopropyl)-27-(4-hydroxybenzyl)-71-((R)-1-hydroxyethyl)-7,39,77-tris(hydroxymethyl)-33-isobutyl-48-methyl-30-(2-(methylthio)ethyl)-2,5,8,11,14,23,26,29,32,35,38,41,44,47,50,53,56,59,62,69,72,75,78,85-tetracosaoxo-18,19,65,66,81,82-hexathia-3,6,9,12,15,22,25,28,31,34,37,40,43,46,49,52,55,58,61,70,73,76,79,84-tetracosaazatricyclo[40.37.4.221,68]pentaoctacontan-24-yl)acetic acid--acetic acid (1/1) |
别名 |
omega-Conotoxin M VIIa acetate | Cys-lys-gly-lys-gly-ala-lys-cys-ser-arg-leu-met-tyr-asp-cys-cys-thr-gly-ser-cys-arg-ser-gly-lys-cys-nh2 acetate | SNX-111 acetate | omega-Conotoxin M VIIa, acetate (salt) | T2I226K69M | UNII-T2I226K69M |
标准英文名 |
2-((1R,4S,7S,13S,16R,21R,24S,27S,30S,33S,36S,39S,42R,45S,48S,54S,60S,63R,68R,71S,77S)-63-amino-13,45,54,60-tetrakis(4-aminobutyl)-16-carbamoyl-4,36-bis(3-guanidinopropyl)-27-(4-hydroxybenzyl)-71-((R)-1-hydroxyethyl)-7,39,77-tris(hydroxymethyl)-33-isobutyl-48-methyl-30-(2-(methylthio)ethyl)-2,5,8,11,14,23,26,29,32,35,38,41,44,47,50,53,56,59,62,69,72,75,78,85-tetracosaoxo-18,19,65,66,81,82-hexathia-3,6,9,12,15,22,25,28,31,34,37,40,43,46,49,52,55,58,61,70,73,76,79,84-tetracosaazatricyclo[40.37.4.221,68]pentaoctacontan-24-yl)acetic acid--acetic acid (1/1) |
分子式 |
C104H176N36O34S7 |
分子量 |
2699.24 |
精确分子量 |
2697.12 |
SMILES |
CC(=O)O.CSCC[C@@H]1NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)[C@@H]2CSSC[C@@H]3NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CSSC[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N2)NC(=O)[C@H](CSSC[C@@H](C(N)=O)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(=N)N)NC3=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC2=CC=C(O)C=C2)NC1=O |
标准SMILES |
CC(O)=O.C[C@@H](O)[C@@H]1NC(=O)[C@@H]2CSSC[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H]3CSSC[C@H](NC(=O)[C@H](CO)NC(=O)CNC1=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC1C=CC(O)=CC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC3=O)C(=O)N2)C(N)=O |
用途 |
Ziconotide acetate is used in chronic pain research; it reduces synaptic transmission by selectively blocking N-type calcium channels. |
InChIKey |
LBACTXHPMJIKTR-XZSNVYKZSA-N |
|
|
评论 |
|---|